 |
 |
|
The widespread availability of antibiotics beginning in the 1940s revolutionized medical care. Today, however, many bacterial infections are developing resistance to the most commonly prescribed antibiotic treatments, and the incidence of "superbugs" is on the rise.
|
Our world's health is at risk. Deadly diseases, once though conquered, have reemerged in drug-resistant forms. Globalization — from air travel to food production — has opened new doors for bacteria and viruses to enter the U.S. One of CDC's most visible roles is identifying and controlling outbreaks of infectious diseases and protecting us from emerging infectious threats. The CDC Foundation provides opportunities for organizations in the private sector to support CDC's efforts and join in the fight. Examples of CDC Foundation partnerships that are improving CDC's ability to fight infectious diseases are listed below.
Infectious Disease Programs
 |
Cytomegalovirus (CMV) Seroprevalence Study
To assess cytomegalovirus (CMV) seroprevalence in the current U.S. population and to identify time trends and risk factors for infection. CMV is the most common congenital (present at birth) infection in the United States.
- Funding Partners: GlaxoSmithKline Biologicals
- Program Partners: National Center for Immunization and Respiratory Diseases, CDC
|
|
Get Smart: Know When Antibiotics Work Campaign
To provide resources to support CDC’s national campaign to promote discriminating use of antimicrobial agents. The campaign seeks to change behavior that leads to overuse of antimicrobial agents in adult and pediatric patients.
- Funding Partners: Abbott Laboratories; Advanstar Communications, Inc.; Aventis Pharmaceuticals; Bayer AG; Daiichi Pharmaceuticals Co., Ltd.; GlaxoSmithKline; Hoffmann-LaRoche, Inc.; Ortho-McNeil Pharmaceutical, Inc.; Pfizer Inc
- Program Partners: Multiple state partners; National Center for Immunization and Respiratory Diseases, CDC
|
|
Malaria Research and Reference Reagent Repository
To support a mosquito stock repository that supplies living and preserved laboratory cultured malaria-vector mosquitoes to researchers studying malaria.
- Funding Partners: American Type Culture Collection; The Rockefeller University; Snell Scientifics, LLC; SpringbornSmithers Laboratories; University of California; University of Florida; University of Illinois at Urbana-Champaign
- Program Partners: Coordinating Center for Infectious Diseases, CDC
|
|
MRSA Surveillance
To develop and conduct supplemental surveys to the National Surveillance for MRSA to determine the percentage of
methicillan-resistant Staphylocussus aureus (MRSA) infections acquired through healthcare versus community settings and to explore how outcomes differ for community-acquired and healthcare-acquired MRSA infections.
- Funding Partners: Astellas Pharma US; Pfizer Inc
- Program Partners: National Center for Preparedness, Detection and Control of Infectious Diseases, CDC
Related Information:
|
|
National MRSA Education Initiative
To help parents and healthcare professionals recognize, treat and prevent MRSA skin infections in their families and patients through a national media campaign and
a series of posters, fact sheets, brochures, flyers, e-cards and Web-based content distributed nationwide.
- Funding Partners: Pfizer Inc
- Program Partners: National Center for Preparedness, Detection and Control of Infectious Diseases, CDC
Related Information:
|
|
Organ Transplant Infection Prevention Project
To perform a study and create a repository of specimens that will help clinicians better prevent and treat infections among transplant patients.
- Funding Partners: Gilead Sciences, Inc.; Merck & Co. ; Pfizer Inc
- Program Partners: National Center for Preparedness, Detection and Control of Infectious Diseases, CDC
|
|
Prevent Antimicrobial Resistance in Healthcare Settings Campaign
To develop a series of health communications aimed at increasing awareness among physicians of CDC’s goals of preventing the spread of antimicrobial resistance. The goal of this initiative is to develop an integrated program to prevent emergence and spread of antimicrobial-resistance infections among patients in healthcare settings.
-
Funding Partners: Becton Dickinson and Company; Cubist Pharmaceuticals; Warren y. Jobe; Kimberly-Clark; Ortho-McNeil Pharmaceutical, Inc.; Premier, Inc.; Pfizer Inc.; The Sally Schieffelin Potter Endowment Fund; University of Alabama at Birmingham; Vermont Oxford Network, Inc.; Wellpoint Foundation
- Program Partners: National Center for Immunization and Respiratory Diseases, CDC
|
|
Safe Care Campaign
To develop educational materials for patients and their visitors on how to protect themselves against healthcare-associated infections (HAIs) as part of a national initiative focused on preventing HAIs.
- Funding Partners: Kimberly-Clark
- Program Partners: National Center for Preparedness, Detection and Control of Infectious Diseases, CDC
|
